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Abstract
The metabolic syndrome (MetS) is manifested by a lipid triad which includes
elevated serum triglycerides, small LDL particles, and low high-density lipoprotein
(HDL) cholesterol, by central obesity (central adiposity), insulin resistance, glucose
intolerance and elevated blood pressure, and it is associated with an increased
risk of type 2 diabetes and coronary heart disease. We have developed a new
hypothesis regarding MetS as a consequence of a high intake in carbohydrates
and food with a high glycemic index, particularly fructose, and relatively low
intake of cholesterol and saturated fat. We support our arguments through
animal studies which have shown that exposure of the liver to increased
quantities of fructose leads to rapid stimulation of lipogenesis and accumulation
of triglycerides. The adipocytes store triglycerides in lipid droplets, leading to
adipocyte hypertrophy. Adipocyte hypertrophy is associated with macrophage
accumulation in adipose tissue. An important modulator of obesity-associated
macrophage responses in white adipose tissue is the death of adipocytes. Excess
exposure to fructose intake determines the liver to metabolize high doses of
fructose, producing increased levels of fructose end products, like glyceraldehyde
and dihydroxyacetone phosphate, that can converge with the glycolytic pathway.
Fructose also leads to increased levels of advanced glycation end products. The
macrophages exposed to advanced glycation end products become dysfunctional
and, on entry into the artery wall, contribute to plaque formation and
thrombosis.
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Introduction 
The metabolic syndrome (MetS) is a term that has been used to
encapsulate a cluster of metabolic risk factors associated with insulin
resistance and heart disease. It has become formalized into slightly
different thresholds by the Adult Treatment Panel III (ATP III), the American
Heart Association and the International Diabetes Federation, but all agree
on the following specific criteria: abdominal obesity defined in terms of
large waist girth, high fasting blood glucose, low serum HDL-C, high serum
triglycerides, and elevated blood pressure [1]. Typically, the definition
requires above-threshold measures on at least three of the five criteria. 
Several authors have written detailed reviews of the physiological profile
associated with MetS [1-4]. However to our knowledge, no one has thus
far attempted to provide a comprehensive unifying theory that explains
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the  disease  progression  and  accounts  for  the
diverse physiological pathologies associated with
MetS. Several studies have shown predictive power
of  MetS  beyond  the  effects  of  the  individual
measures [5-7], although others argue that it is 
not a useful diagnostic metric beyond the compo  -
nent  measures  [3].  Nonetheless,  MetS  carries
a substantially  increased  risk  of  atherosclero  -
sis and subsequent cardiovascular disease, and 
is  associated  with  an  increased  likelihood  of
a shortened life span [8]. Over the last several
decades, medical advice, particularly in the United
States, has emphasized the concept that a low-fat
diet is a healthy diet, and this has likely led to
a shift towards an increased dietary intake in
carbohydrates.  However,  recent  studies  have
demonstrated that a low-carbohydrate diet leads
to improvements on a number of measures related
to heart disease and diabetes risks [9, 10]. As
a consequence of these contradictions, considerable
confusion exists as to what constitutes healthy
eating. A case in point is the recent review article
on recommended lifestyle changes to improve
cardiovascular risk factors, which recommended
reduced  fat  intake  twice  and  recommended
reduced  carbohydrate  intake  twice,  while
suggesting that protein intake should remain under
20% of total calories [11]. 
Fortunately, substantial recent research has
uncovered a large amount of detailed information
about the intricate biological processes concerned
with cholesterol, fatty acid, and glucose homeo  -
stasis. Of particular note for our purposes is the low
serum HDL-C associated with MetS. In a study of
7-year-old children, it was shown that already by
this young age there existed a correlation between
low serum HDL-C and an overabundance of small
LDL particles [12]. This effect preceded any evidence
of MetS, suggesting that this feature is indeed 
an early indicator of the syndrome. It has been
further observed that the HDL is also depleted in
cholesterol. In fact, there is an inverse relationship
between the degree of insulin resistance and the
amount of cholesterol contained in HDL [13, 14],
a highly significant fact that motivates our argu  -
ments. 
The big picture 
In this paper, we developed a theory accounting
for  all  the  features  of  MetS,  which  involves
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to exposure to glucose and fructose. (2) Adipocytes depend upon apoE (E) to scavenge glycated LDL-C and transport
it into HDL-A1 (H). (3) ApoE becomes damaged and adipocytes accumulate lipid droplets (F) and excess cholesterol
(C) in their endoplasmic reticulum (ER). Meanwhile, plasma membrane becomes cholesterol-depleted. Stressed
adipocytes release angiotensin-II (AT-II) which leads to sodium-hoarding and hypertension. (4) Macrophages enter
adipose tissue to engulf cell debris from accumulating dead adipocytes, forming multi-nucleated giant cells. (5) Due
to insufficient HDL-C, fatty deposits accumulate ectopically to buffer cholesterol supplies to the major organs
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a cascade of events brought on by gross dietary
imbalances. We argue that this syndrome has
reached epidemic proportions due to misguided
advice regarding a “healthy” lifestyle, leading to
reduced dietary intake of fats and cholesterol 
and excessive sun avoidance. The increasingly
widespread availability of highly processed foods,
particularly the practice of substituting fructose 
for  glucose  as  a sweetener  due  to  economic
considerations, has been an equally damaging
contributing factor. Calcium and vitamin D defi  -
ciency play a role as well. 
It is hypothesized (Fig. 1) that the condition may
begin with liver dysfunction in converting fructose
to fat and struggling to produce enough cholesterol
to buffer the synthesized fat. The liver then falls
behind in its role in processing glucose, leaving
a large percentage of this burden to adipocytes.
Adipocytes  are  also  tasked  with  recycling  the
cholesterol extracted from serum LDL that has
become  damaged  due  to  excess  exposure  to
glucose and fructose. Over time, the adipocytes’
protein synthesizing machinery becomes defective.
The adipocytes become engorged with fat stores,
and are unable to maintain a healthy plasma
membrane  (PM).  Their  last  act  is  to  release
cytokines calling in macrophages in anticipation of
their  imminent  disintegration.  Eventually,  the
adipose tissue becomes riddled with giant cells,
multinucleated macrophages attempting to protect
the contents of dysfunctional adipocytes from
further glycation, fructation, and oxidation. 
The stressed adipocytes and their accumulating
macrophage  assistants  release  hormones  and
peptides that trigger a cascade of events with the
goal of assuring that the tissues are adequately
supplied with fat and cholesterol, a feat that they
are nonetheless unable to accomplish in the face
of continuing chronic exposure to excess fructose
and glucose. PM of active cells in the pancreas, the
liver, the heart, the kidneys, the skeletal muscles,
and  the  blood  serum  organelles  all  become
deficient  in  cholesterol  and  therefore  highly
vulnerable to attack by sugars and oxygen. The
body accumulates ectopic deposits of fats and
cholesterol in order to provide these vital nutrients
when necessary. Glucose and fructose accumulate
in the bloodstream in ever greater amounts due to
the damage accrued by the β cells in the pancreas
and the reduced ability of the heart and skeletal
muscles  to  utilize  sugars  as  fuel  due  to  their
compromised PM. 
Liver dysfunction associated with high 
fructose diet 
Several experiments have been performed, on
both humans and animal models, that clearly show
that fructose is highly damaging to health [15-18].
In experiments with rats, fructose has been shown
to induce hypertension [16], increased arterial
stiffening  due  to  damage  to  collagen,  and
decreased cardiac output [17]. In a recent clinical
trial  [19],  it  was  shown  that  fructose  over-
consumption in humans leads to dyslipidemia and
ectopic  lipid  deposition,  along  with  increased
hepatic insulin resistance. In a crossover design,
both  hepatic  lipids  and  VLDL  triacylglycerides
increased by over 75% following a short-term high-
fructose diet. Lipids stored in skeletal muscle cells
also increased significantly. Furthermore, whole-
body  insulin  sensitivity  decreased  by  27%.  In
another study comparing 20 type 2 diabetics on
oral medication with normal controls, it was found
that,  while  the  ratio  of  Haemoglobin-A1c
(haemoglobin  damaged  by  glucose  exposure)
between the diabetics and the controls was less
than  2.0  (9.3  vs.  5.4),  the  ratio  of  serum
fructosamine levels differed by a factor of 7 (1127
vs.  170)  [20].  Controlled  dietary  experiments
conducted with baboons and with hamsters offer
compelling evidence for the damage that chronic
fructose exposure does to the liver. 
D Di ie et ta ar ry y   e ex xp pe er ri im me en nt ts s   w wi it th h   b ba ab bo oo on ns s   
An experiment conducted in the mid 1970s with
baboons [21] involved feeding them a synthetic
zero-cholesterol diet. Four test groups were fed
different proportions of starch, glucose, fructose,
and  sucrose,  supplemented  with  appropriate
amounts of other dietary requirements besides
cholesterol. All of the test groups exhibited an
increase in serum triglycerides ranging from 37%
in the starch and glucose-fed groups to 65% in the
fructose-fed group. Liver triglyceride and cholesterol
were elevated in all groups. An analysis of bile acid
composition indicated a reduced conversion of
cholesterol  to  bile  acids.  All  tested  animals
developed fatty streaks in the aorta, something that
is unusual for this species. The severity of fatty
streak development was greatest for the fructose-
fed group. 
D Di ie et ta ar ry y   e ex xp pe er ri im me en nt ts s   w wi it th h   h ha am ms st te er rs s   
Hamsters are valuable as a model for humans
due  to  their  similar  lipoprotein  management
system, in contrast to rats and mice. A study
involving both in vivo and in vitro investigations of
the  effects  of  fructose  on  fat  and  cholesterol
metabolism in hamsters [22] provides great insight
into the source of liver dysfunction in the metabolic
syndrome. Hamsters were fed a high fructose diet
for  a two-week  period,  at  the  end  of  which
measures were made of blood serum levels of
a number of indicators of MetS. A more than 3-fold
increase was found in the amount of triglyceride in
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the serum of the fructose-fed hamsters compared
to controls, as well as a significant elevation of free
fatty acids (FFA) and insulin. A reduction in tyrosine
phosphorylation of insulin receptor in the hepatic
cells indicated insulin resistance. 
After the two-week period, hepatic cells were
isolated and grown in medium. Measures were
made  of  both  internal  and  secreted  levels  of
cholesterol, triglycerides, and apolipoprotein B
(apoB). It became clear that fructose-fed hamsters
retained significantly more fat stores in the liver,
with a concurrent 50% increase in internal storage
of free cholesterol. There was a 4.6-fold increase in
the amount of VLDL apoB secreted, along with
a significantly enhanced intracellular stability of
apoB. Most significant for our purposes, the amount
of  free  cholesterol  released  by  fructose-fed
hamsters was reduced by more than 50%, and the
released VLDL particles contained significantly less
cholesteryl ester relative to their triglyceride levels;
i.e., these particles were depleted in cholesterol.
Overall, it seems clear that the hamsters were
forced to retain free cholesterol within the liver to
buffer the fatty acids synthesized from the fructose.
This prevented them from releasing sufficient
cholesterol to the serum, which, over time, leads to
insufficient cholesterol supplied to the tissues. At
the  same  time,  their  insulin  resistance  was
conceivably  due  to  the  fact  that  they  were
compelled to synthesize cholesterol, and insulin
suppresses cholesterol synthesis [23]. 
A novel theory for the metabolic syndrome 
In  our  view,  MetS  arises  out  of  a dietary
imbalance with an overabundance of refined, high-
glycemic  index  carbohydrates,  most  notably,
fructose,  and  a relative  dietary  deficiency  in
cholesterol.  A recently  published  paper  [24]
demonstrated an intriguing relationship between
fasting glucose level and cholesterol metabolism.
For people exhibiting insulin resistance, choleste  -
rol synthesis was upregulated and cholesterol
absorption was downregulated, independent of
obesity level. This suggests that a dietary deficiency
in cholesterol, or an impaired ability to absorb it,
may be associated with insulin resistance. 
A study of the relationship between dietary
cholesterol  and  serum  cholesterol  in  rats,
undertaken in the mid 1970s, uncovered some
surprising results [25]. Most notably, a cholesterol-
free  diet  resulted  in  greater  accumulation  of
cholesterol in adipose tissue than a diet enriched
with 0.05 or 0.1% cholesterol. Furthermore, even
up to a 5% cholesterol diet, serum cholesterol
concentration was inversely related to dietary
supply after a two-month interval. These authors
also demonstrated compellingly that the amount
of  cholesterol  stored  in  adipose  tissue  is
proportional to the amount of triglycerides stored.
Leptin-deficient (ob/ob) mice, (a model of type 2
diabetes with relatively mild hyperglycaemia and
obesity) had five times the adipose mass of controls,
and 1.2- to 2-fold differences in fat cell diameter,
yet  the  cholesterol  to  triglyceride  ratios  were
identical between the two groups. 
Fructose is especially damaging because it is
highly reactive as a reducing agent, and the liver
must remove it aggressively from the blood serum
to prevent it from damaging serum lipids and
proteins  via  fructation  [26].  With  a high-
carbohydrate, low-fat diet, postprandial fructose
and glucose enter the bloodstream very rapidly due
both to the abundance of refined carbohydrates
and to the lack of buffering in the gut by dietary
fats. The tissues are reluctant to utilize fructose as
fuel, likely because it is ten times as reactive as
a reducing agent as glucose [26]. 
An  excess  of  fructose  and  glucose  in  the
bloodstream causes extensive glycation damage to
vulnerable proteins [27, 28]. A glycated (whether
fructated or glucated) protein is typically both
impaired in its function and more susceptible 
to  oxidation  damage.  It  is  also  resistant  to
degradation through lysosomal breakdown. Over
time, a collection of glycated protein debris accu  -
mulates in the blood serum and along arterial walls.
These damaged proteins are referred to collectively
as advanced glycation end products (AGEs) [29],
and they play a critical role in aging, in athero  -
sclerosis, and in the health issues associated with
long-term diabetes. Collagen, haemoglobin, LDL,
and albumen are all susceptible to AGE damage. In
particular, the lysine residues of apo-B in LDL are
susceptible to glycation and, once they are glycated,
LDL  is  only  poorly  recognized  by  lipoprotein
receptors and scavenger receptors [30]. A schematic
of the receptor-mediated uptake of cholesterol and
fatty acids from LDL is illustrated in Figure 2 and an
illustration of impairment of this process through
glycation is given in Figure 3. 
Glycation of LDL also causes it to be more
susceptible to oxidation damage. A study of the
potential effects of lipoprotein glycation on the
oxidation  of  contained  cholesteryl  esters  was
conducted by Ravandi et al. [31]. In controlled in
vitro experiments, the presence of a synthesized
glucosylated lipid, phosphatidylethanolamine (Glc
PtdEtn) resulted in a 4- to 5-fold increase in the
generation of oxidation products such as hydro  -
peroxides and aldehydes. Furthermore, when this
AGE  product  was  included  in  the  LDL  lipid
monolayer, it resulted in rapid loss of cholesteryl
esters from the interior. The authors concluded that
the presence of glucosylated phospholipids in the
membrane may promote oxidation of both the
membrane phospholipids and cholesteryl esters in
the interior of the particle. 
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Cholesterol and fats that are delivered to the
cells  from  food  sources  arrive  in  the  form  of
a chylomicron, a spherical particle that is also
encased in a lipoprotein shell, but is at least an
order of magnitude larger than LDL. Lipoproteins
range in diameter from 8 Angstroms for HDL [32]
to around 250 Angstroms for LDL [12] whereas the
chylomicron can be as large as 5000 Angstroms
[32]. This large size offers superior protection of its
contents from oxidation. Indeed, given the choice,
the  heart  will  preferentially  take  up  fats  and
cholesterol from the chylomicron rather than from
LDL [33]. Simple geometry tells us that a sphere
whose radius is ten times larger than that of
another  sphere  contains  1000  times  as  much
content with only 100 times as much surface area.
Thus, it would take 1000 LDL particles to contain
the equivalent content of a single chylomicron ten
times as large in diameter, and it would require ten
times as much cholesterol and lipoprotein to encase
those contents. 
It  is  commonly  believed  that  the  body  can
synthesize all the cholesterol and fats that it needs,
but this may not be true, because the liver becomes
overburdened with its many tasks when the diet is
so skewed. Furthermore, cholesterol synthesis in
the liver, a complex 25- to 30-step process, may be
relatively suppressed when insulin is present. The
liver has to take up excess fructose as quickly as
possible  to  prevent  it  from  damaging  serum
proteins. After a meal, the liver rapidly processes
the fructose to basic building blocks that can later
be converted to fat, but it can neither safely store
the fat nor release it within newly synthesized
lipoproteins. This is the key factor that leads to both
fatty  liver  and  liver  insulin  resistance,  early
indicators of the metabolic syndrome. 
The  liver  releases  its  synthesized  fats  and
cholesterol as VLDL particles, which deliver fat,
cholesterol, and antioxidants to all the tissues, while
becoming steadily smaller as they migrate through
stages of IDL, LDL, and, finally, VLDL remnants, also
known as small dense LDL: small lipoprotein shells
with minimal content but damaged by exposure to
glucose,  fructose,  and  oxygen.  The  liver  is
responsible for recycling these remnants through
bile excretion to aid in the digestion of fats (and to
be  reconstituted  as  free  cholesterol  in  the
membrane  and  esterified  cholesterol  in  the
contents of the chylomicron). When there are
relatively few fats in the diet, less bile is needed,
and the liver, being burdened by fructose and
glucose metabolism, falls behind on the task of
providing cholesterol to the bile salts. 
Meanwhile, the task of cleaning up damaged
VLDL remnants is delegated to the adipocytes. In
particular, they synthesize substantial amounts of
apoE to reconstitute damaged cholesterol and
orchestrate its transport to PM so that it can be
utilized both by the adipocyte itself and by many
other cells in the body (after it is taken up by HDL
particles  in  the  bloodstream).  Over  time,  the
adipocyte accumulates AGE products due to its
chronic exposure to both glucose and damaged
VLDL remnants. ApoE is especially susceptible to
AGE damage [34], and, eventually, it can no longer
function. This leads to the accumulation of excess
free cholesterol within the adipocyte, ironically while
it is suffering from cholesterol deficiency in its outer
wall. The adipocytes are required to store the excess
cholesterol. However, the increased size requires
a corresponding expansion in the surface area.
Without sufficient cholesterol in the PM, the cell
becomes first permeable to outward sodium leaks
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represents the normal binding of the apolipoprotein
(A) and absorption of an LDL particle (L), which has
attached to the receptor (R). The activated receptor
has  caused  the  formation  of  a caveolus  for
absorption from the blood vessel (V) by endocytosis
through the cell membrane (M). These functional
membrane changes are facilitated by cholesterol and
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schematic the lysine in apoB or E (A) has become
damaged  by  glycation  (D).  Consequently,  the
receptor (R) is unable to recognize the LDL particle
(L). The cell endocytosis via the cell membrane (M)
does not occur. The damaged LDL will circulate until
a less  discriminating  scavenger  receptor  in  an
adipose cell takes it up for recycling 
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but ultimately unable to keep calcium out, at which
point the cell literally disintegrates. 
Macrophages are responsible for engulfing lipids
that are exposed to the interstitial spaces, so they
rush in to clean up the cell debris left behind by
dead  adipocytes.  In  fact,  so-called  giant  cells
accumulate in unhealthy adipose tissue: a single
cell encasing multiple cell nuclei and lipid droplets
[35]. Such a cell is likely taking advantage of the
same principle as that used by the chylomicron.
A single PM surrounding multiple cell nuclei requires
significantly less cholesterol to protect the contents
from damage than would several individual cell
walls. The macrophages secrete various inflam  -
matory agents such as interleukin (IL)-6 and tumour
necrosis factor-α (TNF-α). 
Over time, more and more adipocytes swell in
size to the point of cell death to accommodate
cholesterol that they cannot discharge, and the
subcutaneous  adipocytes  become  increasingly
unable to deliver refurbished cholesterol to the
tissues. Cholesterol deficiency becomes a problem
for  cells  throughout  the  body,  with  dire
consequences.  One  consequence  will  be  the
increased  susceptibility  of  the  fats  in  cell
membranes to oxidation [36]. This problem can be
partially ameliorated through the accumulation of
fat storage in non-adipocyte cells in and among the
viscera,  including  the  heart,  i.e.,  ectopic  fat.
Epicardial fatty deposits (and ectopic fat in general)
serve as a private source of fats and cholesterol to
replenish supply to repair damaged membranes
when blood serum levels are insufficient. 
Initially, it is only the liver that is resistant to
insulin, but the skeletal muscles and adipocytes also
show signs of insulin resistance as they become
exposed to accumulated AGE damage. The resulting
excess of glucose in the blood leads to a sharply
increased  demand  for  insulin,  which  imposes
excess energy requirements on the β cells in the
pancreas, leaving them susceptible to glycation and
oxidation damage as well. β cells require glucose,
calcium, fats, vitamin D and cholesterol to all be
present at adequate levels in the cytoplasm before
they will release insulin. Due to deficiencies in these
nutrients, the β cells eventually become dysfun  -
ctional leading to diabetes. 
Adipocytes and cholesterol homeostasis 
The liver is the primary source of synthesized
cholesterol, which supplies the body’s supplemental
needs  when  dietary  cholesterol  is  deficient.
However, the adipocytes from the adipose tissue
are mainly responsible for buffering up cholesterol
stores  to  be  released  into  the  bloodstream
whenever demand exceeds immediate supply from
the liver. Adipocytes are unique in their ability to
store free or unesterified cholesterol, but they can
only do so if they also contain a proportional
amount  of  lipid  droplets  [37].  ApoB-100,  the
apolipoprotein found in LDL, inhibits lipolysis in
adipocytes, whereas apoB-48, the one found in the
chylomicron, does not [38]. Thus, if LDL levels are
high, and the chylomicron supply is depleted, fats
will accumulate in the adipocytes, and the reason
is likely because they are needed to buffer the
stored cholesterol. 
The free cholesterol is stored in a lipoprotein
monolayer encasing the lipid stores, which also
uniquely contains proteins involved in protein
folding and normally found in the endoplasmic
reticulum (ER). Thus, it is becoming apparent that,
in adipocytes, the ER forms an intimate relationship
with  lipid  droplets,  and  a constant  exchange
between free and esterified cholesterol tightly
controls the amount of free cholesterol present in
the  ER  membrane.  Ordinarily,  there  is  also
a constant exchange between the free cholesterol
found in the ER and that in the PM, with exodus
from the cell into the serum being triggered by the
needs of the body’s other tissues. 
The adipocytes are also assigned the arduous
task of reconstituting cholesterol derived from
damaged VLDL remnants, the so-called small dense
LDL that are considered the most damaging in the
atherosclerosis process. This task is also normally
assumed by the liver as well, but under conditions
of excess fructose the liver is overwhelmed and
unable to keep up. Adipocytes synthesize large
amounts of apoE, which is a necessary catalyst for
both the uptake of damaged LDL and the release
of the reconstituted cholesterol back into the
bloodstream as HDL-C [39, 40]. The LDL is broken
down into lipids, proteins, and cholesterol in the
lysosome, and the cholesterol must be refurbished
by apoE before it can return to the membrane for
absorption into HDL. ApoE, being an antioxidant, is
itself especially susceptible to excess glycation and
oxidation, which causes it to perform inadequately.
Once  damaged,  apoE  can  no  longer  promote
transfer of refurbished cholesterol to the PM. The
adipocyte then accumulates an excess of cholesterol
which needs to be buffered by fats or else it will
crystallize and become toxic to the cell. Hence the
adipocyte is compelled to become engorged with
excess fatty acids. An early study [41], recognizing
a unique aspect of adipocytes with respect to LDL
uptake, hinted at the idea of AGE’d LDL and the
possibility  that  adipocytes  dispose  of  it.  They
observed that fat tissue is “a very large cholesterol
storage  organ”.  Their  studies  verified  that
adipocytes  are  able  to  “bind,  internalize,  and
degrade” significant amounts of methylated LDL.
Methylation is similar to glycation in that methyl
radicals bind to the lysines in ApoB. They observed
that there is a “unique physiological function of
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adipocytes  to  store  rather  than  shun  free
cholesterol”. Most remarkably, they showed in in
vitro experiments that an excess of unmethylated
LDL in the medium increased the adipocytes’ rate
of degrading methylated LDL. This suggests that
adipocytes are able to selectively degrade and clear
damaged LDL. 
Another piece of the puzzle is the roles played
by calcium and vitamin D. Calcium transport across
the ER membrane is crucial for the protein folding
step that is required to synthesize viable proteins
in  the  ER  [42].  Vitamin  D  catalyzes  calcium
transport.  Furthermore,  the  ER  membrane  is
typically depleted in cholesterol compared to the
PM, and this gives it greater fluidity to calcium.
When cholesterol builds up in the ER, because it is
unable to migrate to the PM, the ER becomes stiffer
and resistant to calcium transport. This results in
dysfunctional protein folding machinery, which may
be the primary factor contributing to subsequent
cell  death.  Meanwhile  the  PM  becomes  more
permeable due to cholesterol depletion, leading
initially to excess sodium leakage but ultimately to
membrane disintegration and cell death. 
I In n   v vi it tr ro o e ex xp pe er ri im me en nt ts s   w wi it th h   c ch ho ol le es st te er ro ol l   
d de ep pl le et ti io on n   
A research  study  involving  manipulation  of
cholesterol in the PM of adipocytes has led to great
insight regarding the crucial role cholesterol plays
in insulin resistance and the inflammatory response
[43].  The  authors  propose  that  intracellular
cholesterol might serve as a link between fat cell
size and adipocyte metabolic activity. In in vitro
experiments,  fat  cells  isolated  from  rat  sub  -
cutaneous fat tissue were treated with increasing
concentrations of methyl-β-cyclodextrins (MβCD),
which extract cholesterol from the PM. The cells
responded in a dose-dependent manner by (1)
activating  genes  associated  with  cholesterol
synthesis, uptake, and transport, as would be
expected (2), upregulating expression of fatty acid
synthase (FAS) and downregulating expression of
the insulin-regulated glucose transporter type 4
(GLUT4),  activities  associated  with  insulin
resistance,  and  (3)  upregulating  angiotensin, 
TNF-α, and IL-6, all known to be involved in the
inflammatory  stress  response  of  metabolic
syndrome.  The  authors  hypothesize  that  dis  -
organization of cholesterol-rich caveolae, in which
the  insulin  receptor  is  located,  might  play  an
important role in insulin resistance. It can be
concluded  that  engorged  adipocytes  in  MetS
manifest a metabolic profile strikingly parallel with
that induced by artificially extracting cholesterol
because they too are suffering from cholesterol
deficiency in the PM. 
E En nd do op pl la as sm mi ic c   r re et ti ic cu ul lu um m   d dy ys sf fu un nc ct ti io on n   d du ue e   t to o
c ch ho ol le es st te er ro ol l   l lo oa ad di in ng g   
We thus hypothesize that adipocytes become
stressed upon depletion of cholesterol in their PM,
concurrent with an excess of cholesterol in the ER.
They are compelled to obtain an increased supply
of fatty acids. Thus they must synthesize fatty acids
from glucose, in order to be able to safely store the
excess free cholesterol that they are unable to
transport to the membrane due to damaged apoE. 
At the same time, excess cholesterol in the ER
leads to a reduced rate of transfer of calcium across
its membrane due to a decrease in membrane
fluidity. Calcium is essential for chaperone proteins
such as binding immunoglobulin protein (BiP) that
are involved in protein folding in the ER. Therefore,
the cells begin to hoard calcium and vitamin D as
compensation. 
BiP has become recognized as a ubiquitous
protein found in the ER, and it plays a key role as
a chaperone for protein folding to realize the correct
tertiary structure for proper functioning [42]. BiP
directly binds to growing chains and stimulates
ATPase activity to generate energy. When BiP is
dysfunctional, misfolded proteins must be disposed
of by proteolytic breakdown. The ER lumen where
BiP  operates  is  characterized  by  a high  con  -
centration  of  free  calcium.  Likely  due  to  the
importance of calcium to BiP function, BiP plays an
important  role  in  the  storage  of  the  rapidly
exchanging calcium pool. When the ER becomes
over-supplied with cholesterol, its membrane fluidity
is reduced, which interferes with the free flow of
calcium across the membrane. This leads to calcium
depletion in the lumen and an inability to properly
fold proteins being synthesized, and likely will
cascade to cell death if the situation is not repaired.
A temporary fix is to hoard excess calcium along
with  excess  vitamin  D  to  promote  calcium
transport. This in turn leads to extreme deficiencies
of both calcium and vitamin D in the blood serum. 
Macrophages and designer mice –
the essential roles of BiP and acyl-CoA 
– cholesterol acyltransferase 
Cholesterol loaded macrophages (foam cells) are
a prominent component of atherosclerotic plaque,
and  it  is  well  accepted  that  they  contribute
significantly to the progression of advanced lesions
[44]. Macrophage foam cells are created by the
uptake of oxidized LDL, which in turn is actively
induced in the artery wall by reaction with nitric
oxide and H2O2 under oxidative conditions [45]. The
oxidized LDL enters the lysosome, and the extracted
cholesterol is delivered to the PM in just 40 minutes
[46] via a mechanism that involves apoE. It is only
after excess cholesterol has accumulated in the PM
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that cholesterol is then returned to the cytoplasm
and converted via acyl-CoA:cholesterol acyltrans  -
ferase1 (ACAT1) into cholesterol esters to be stored
in accumulating lipid deposits, thus converting the
macrophage into a foam cell. The main purpose for
extracting cholesterol from damaged LDL is to
recycle  it  into  HDL-A1,  i.e.,  to  achieve  reverse
cholesterol  transport.  Interestingly,  and  most
significantly, the rate of cholesterol efflux from the
PM  to  apoA1-HDL  is  ten  times  greater  from
macrophage PMs than from smooth muscle cell
PMs. 
A AC CA AT T   i is s   e es ss se en nt ti ia al l   t to o   m ma ac cr ro op ph ha ag ge e   h he ea al lt th h   
Over the last few decades, researchers have
become  increasingly  sophisticated  in  applying
techniques that involve designer mice to help
unravel the mysteries of atherosclerotic plaque
build-up. While these experiments have been very
fruitful, they have sometimes led to extremely
surprising results. Overall, it seems clear that the
macrophages present in large numbers in the
atherosclerotic plaque play an extremely important
role in repairing damaged cholesterol and delivering
it to HDL. Hence, they are intimately involved in
reverse cholesterol transport, leading to a beneficial
increase in the HDL/LDL ratio. Ill-conceived schemes
to develop drugs that interfere with the process of
cholesterol uptake by macrophages have resulted
in  obvious  failure  [47-49].  But  the  results  are
expected if it is taken the point of view that
macrophages play a crucial positive role that must
be maintained intact. We argue that the plaque
build-up is a direct consequence of the steady
erosion of the ability of adipocytes and liver cells to
participate in reverse cholesterol transport. The
impairments  that  they  develop  over  time  are
a direct consequence of their chronic exposure to
AGE products. Macrophages in the atherosclerotic
plaque eventually succumb to a similar fate, but
not before they have successfully contributed to
refuelling HDL. 
Macrophages in plaque actively take up oxidized
and acetylated LDL and incorporate the extracted
cholesterol into accumulating fatty deposits, and
this process requires esterification utilizing the
enzyme ACAT1 [50, 51]. It had therefore been hoped
that interference with ACAT1 synthesis might reduce
plaque  build-up.  However,  results  have  been
dismally disappointing [47, 48], with plaque build-
up  continuing  unabated  but  with  increased
pathology due to the accumulation of cholesterol
crystals. 
Hyperlipidemic mice, either apoE-/- or LDL-R-/-,
that are also defective in ACAT1 synthesis exhibit
severe pathology in the skin due to the massive
accumulation of extracellular cholesterol crystals,
and die at a young age [49]. Their serum cholesterol
is lowered, but at a severe cost. This result clearly
indicates that ACAT1 functions normally in the skin
and is necessary for the recycling of the cholesterol
extracted from damaged LDL back into HDL for
eventual  delivery  to  the  tissues.  Experiments
cleverly designed to only introduce ACAT1 deficiency
selectively in the macrophages, through marrow
transplantation of defective stem cells, resulted in
an increased area of atherosclerotic lesions heavily
laden  with  cholesterol  crystals,  along  with  an
increase in inflammation [47]. Hence, ACAT1 is
a necessary enzyme for maintaining relatively
healthy plaque, and is part of the solution rather
than part of the problem. 
E Ex xp pe er ri im me en nt ts s   w wi it th h   c ch ho ol le es st te er ro ol l- -l lo oa ad de ed d   
m ma ac cr ro op ph ha ag ge es s   
A set of experiments [52] has demonstrated the
close coupling between phospholipid synthesis and
cholesterol loading. By exposing macrophages to
excess free cholesterol over a period of 4 days, it
was shown that initially the cells remained healthy
but only by synthesizing extra phospholipids to
maintain the proper proportion of cholesterol in the
PM. Eventually, their ability to synthesize sufficient
phospholipids deteriorated. As a consequence, they
became necrotic, with swollen organelles and
disrupted membranes. The authors also showed
that externally supplied cholesterol-depleted HDL
protected the cells from necrosis, by actively taking
up the excess cholesterol in the PM. 
E Ex xc ce es ss s   e en nd do op pl la as sm mi ic c   r re et ti ic cu ul lu um m   c ca al lc ci iu um m   l le ea ad ds s   
t to o   a ap po op pt to os si is s   i in n   m ma ac cr ro op ph ha ag ge es s   
In  a series  of  experiments,  Li  et  al.  [53]
demonstrated compellingly that the accumulation
of excess cholesterol in the ER is the trigger for
ultimate apoptosis of macrophage foam cells in
atherosclerotic  lesions,  which,  in  turn,  likely
contribute  to  plaque  destabilization.  The  ER
membrane achieves its fluidity to transport of small
ions like Na+ and Ca2+ by being relatively depleted
in cholesterol [54]. When the ER is unable to unload
its accumulating free cholesterol to the PM, the
sarcoplasmic reticulum calcium ATPase SERCA2b,
a membrane  protein  that  catalyzes  calcium
transport,  loses  function  due  to  decreased
conformational  freedom.  This,  in  turn,  causes
a depletion of calcium in the ER lumen. Several
proteins involved in orchestrating protein folding,
such as BiP, calreticulin, and calnexin, are calcium
dependent. Low calcium in the ER thus induces the
so-called unfolded protein response (UPR), which
essentially cripples the cell and triggers cell death. 
We propose that a similar process takes place
first in subcutaneous adipocytes, whose apoE has
been chronically exposed to AGE debris. Initially the
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adipocytes attempt to compensate by hoarding
calcium, but ultimately they succumb and become
scavenged by macrophages, which take on the
dangerous  task  of  clearing  damaged  LDL.
Macrophages also make their way into the ectopic
fatty deposits in the major organs, and there, too,
they eventually succumb to glycation and fructation
damage and suffer a similar fate. The macrophages
in the cardiac arterial wall are the last frontier,
forced to take on the task of recycling damaged LDL
because the subcutaneous and ectopic fatty tissues
are already severely compromised. 
Calcium and vitamin D deficiency in the obese 
Calcium and vitamin D deficiency in the obese
has been attributed to excessive storage of 25-
hydroxyvitamin D in adipose tissue. Zemel et al. [55]
claim that low calcium diets promote excess storage
of fats in fat cells. They have confirmed in studies
with rats as well as through both epidemiological
and  clinical  trial  data  with  humans  that  high
calcium intakes afford protection from obesity. They
and others [56] have observed, for obese people,
a significant  weight  loss  associated  with
augmented calcium ingestion, whether through
calcium supplements or via dietary adjustments.
Calcium  obtained  from  dairy  products  was
particularly  effective  as  compared  with  other
sources of calcium. This is likely because lactose
enhances intestinal absorption of calcium [57]. 
It has been known for some time that patients
following gastric bypass surgery suffer from severe
vitamin D deficiency. However, it has also been
noted  that,  even  before  bypass  surgery,  the
morbidly obese are vitamin D deficient [58]. In our
view,  their  abundant  oversized  adipocytes  are
hoarding vitamin D along with calcium because
vitamin D catalyzes calcium transport. 
Pancreatic β β cell dysfunction and insulin
resistance 
Pancreatic β cells are the sole producers of
insulin.  Beta  cells  have  stringent  nutrient
requirements before they will release insulin into
the  bloodstream.  In  particular,  there  must  be
sufficient amounts of cholesterol [59], vitamin D
[60], calcium [59, 61] and fats [61] available in the
cytoplasm, as well as an abundant supply of glucose
to fuel the synthesis and release of insulin. 
In experiments where the squalene epoxidase
inhibitor NB598 was used to selectively impair
cholesterol synthesis in mouse pancreatic β cells,
it was demonstrated that insulin secretion in the
presence of glucose was significantly impaired, and
that this was largely due to inhibition of voltage-
gated calcium channels [59]. Both the release of
granules stored in membrane-associated releasable
vesicles and the refilling of these vesicles were
impaired. 
Li  et  al.  [62]  have  demonstrated  through
experiments with Syt-VII-/-mice that calcium is
essential both for insulin transport to the PM in β
cells and for GLUT4-mediated glucose uptake by
skeletal  muscles  and  adipocytes.  Syt-VII  is
a synaptotagmin which serves as a calcium sensor
for vesicular traffic, and it mediates secretory
granular  exocytosis.  It  regulates  both  insulin
secretion by β cells and GLUT4 translocation in
insulin-sensitive tissues. Syt-VII-/-mice are glucose
intolerant and exhibit significantly less insulin
secretion than their control littermates. 
We explained above that adipocytes would hoard
calcium because their ER is super-saturated in
cholesterol. It is evident, however, that serum
calcium deficiency will lead to impairment in both
insulin release and glucose uptake, as an indirect
consequence of adipocyte dysfunction. A cha  -
racteristic of obesity is excess leptin and suppressed
adiponectin signalling. Insufficient adiponectin
promotes insulin resistance and the preferential
uptake of fats over glucose in the muscle cells [63],
and its intentional suppression is likely related to
an anticipated impairment in glucose metabolism
due to calcium depletion. 
This situation is further aggravated by poor
calcium absorption in the gut. Fats promote calcium
absorption, and dietary fibre interferes with it [64].
So a high-fibre diet, if associated with a stringent
low-fat diet may compound the problem of insulin
resistance and β cell dysfunction. 
Lipid rafts, bile salts, and HDL-C 
Epidemiological studies have demonstrated the
significant inverse relationship between HDL-C and
coronary atherosclerosis. The Framingham Heart
Study  reported  that  HDL-C  had  the  strongest
inverse relationship to incidence of CAD, and that
depleted  cholesterol  in  HDL  is  the  best  lipid
predictor of coronary artery disease for people over
50 years old. HDL-C is also an important predictor
for chances of surviving bypass surgery. Foody et
al. [65], in a clinical study at the Cleveland Clinic,
found that men whose HLD-C was in the lowest
quartile had a 33% reduced chance of survival after
15 years. In general, a 1 mg/dl increase in HDL-C
level is associated with a significant reduction in
CAD risk of 2% in men and of 3% in women. 
The HDL receptor SR-BI plays a critical role in
reverse cholesterol transport [66], returning spent
lipoproteins to the liver so that they can be recycled.
Under normal conditions, the extracted cholesterol
is secreted to the gall bladder to be incorporated
into bile acids, which promotes the digestion of fats.
The refurbished cholesterol is then reintroduced to
the tissues along with the fats via the chylomicron.
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This then becomes an important source of high
quality cholesterol for the tissues through a “back
door” pathway. 
It has recently become clear that the PM is
a much more complex structure than had previously
been thought, and attention has focused on the
increasingly accepted idea that so-called lipid rafts,
cholesterol and sphingolipid enriched domains, play
an important role in the mediation of transport of
fatty acids and glucose across the PM through their
involvement in a variety of signalling pathways [67]. 
Given the hypothesis that lipid rafts and caveolae
might play a role in cholesterol metabolism in the
intestine, researchers at the University of Iowa [68]
conducted experiments on human small intestine
cells to detect the presence of caveolin mRNA. They
confirmed  its  presence  and  determined  that
caveolin is associated with detergent-resistant
microdomains of cellular membranes, i.e., with 
lipid rafts. Cholesterol is transported from these
caveolae to the ER for esterification and eventual
incorporation into the chylomicron. This process
likely requires sufficient dietary fat to associate with
the esterified cholesterol, to prevent toxicity. Hence,
the amount of cholesterol in bile salts has to be
kept in check if dietary fats are depleted. 
An experiment where human caveolin-1 and
caveolin-2 were transfected into hepatocytes in
mice showed clearly that caveolins are also heavily
involved in bile salt export [69] from the liver. Serum
HDL-C  was  also  significantly  increased  in  the
transfected mice. It follows logically that a reduction
in  bile  salt  export  would  likely  correspond  to
a reduction in serum HDL, i.e., a less favourable
profile for atherosclerosis. A low-fat high-fructose
diet would lead to a reduction in bile salt export,
due to both the decreased need for bile salts to
digest fats and the increased load on the liver to
synthesize  and  store  sufficient  cholesterol  to
associate  with  the  accumulating  fat  deposits
synthesized from the fructose. 
Adipocytes release angiotensin II when
stressed 
The depletion of cholesterol in the adipocyte PM
leads to sodium leaks [36], and this will result in
excess serum sodium and in the activation of the
renin–angiotensin system, which in turns causes
profound vasoconstriction with a resulting increase
in blood pressure. Hypertension is one of the salient
features of MetS [1]. 
Angiotensin II has also been shown to increase
the gene expression of inflammatory agents, and
decrease  adiponectin  expression  [70].  Since
adiponectin increases insulin sensitivity in skeletal
muscles, its decrease will promote insulin resistance
and a preference for fatty acids over glucose as
substrate. This is likely an endocrine action on the
part of adipocytes induced to protect skeletal
muscles, likely also depleted in PM cholesterol, from
potential  glycation  and  oxidative  damage  to
myoglobin as a consequence of excess vulnerability
without the protection afforded by cholesterol in
lipid rafts. 
Angiotensin  II  has  a complex  and  highly
significant  effect  on  apoE  expression,  sharply
decreasing  its  synthesis  in  adipocytes,  while
increasing its expression in peritoneal macropha  -
ges [70]. This suggests that the intent is to trans  -
fer control of clearance of damaged LDL from
adipocytes to macrophages, since the adipocyte can
no longer safely execute this function. Through in
vitro  experiments,  it  has  been  demonstrated 
that oxidant stress sharply downregulates apoE
expression in adipocytes in obesity [71]. 
Angiotensin II, similar to insulin, increases the
expression of SR-BI in adipocytes, which promotes
the uptake of cholesterol from HDL [72]. Ironically, the
adipocyte must extract cholesterol from HDL to supply
additional cholesterol to its expanding PM, while
simultaneously accumulating excess fats (synthesized
from glucose) to allow it to safely store the excess
free cholesterol trapped internally in the ER. 
Experiments with genetically engineered
obese mice 
Genetically manipulated mice have become
a valuable resource for uncovering the metabolic
effects of obesity and the roles that adiponectin
and leptin play in controlling homeostasis. A recent
study [73] compared three mouse phenotypes: WT
(wild  type  controls),  ob/ob  (obese  mice  with
defective leptin synthesis) and transgenic (ob/ob
mice engineered to over-express adiponectin).
Interestingly, the transgenic mice grew even more
obese than the ob/ob mice, but their subcutaneous
fat tissues were characterized by both significantly
less macrophage penetration and a larger number
of fat cells with much smaller average size. The
authors hypothesized that, in the case of the ob/ob
mice, necrosis due to membrane disruption of
engorged  adipocytes  led  to  the  infiltration  of
macrophages and subsequent release of inflam  -
matory agents. 
The  transgenic  mice  exhibited  improved
prognosis on a number of indicators of MetS,
compared to ob/ob – improved insulin sensitivity,
substantially reduced ectopic fat deposition, and
lower fasting glucose, triglyceride and FFA levels.
However, they clearly were not healthy, in that they
behaved as if they were starved. They were very
inactive, and unable to maintain body temperature
in  cold  conditions.  Furthermore,  and  most
significantly, while they deposited very little visceral
fat elsewhere, they exhibited a five-fold increase in
pericardial fat deposits. During fasting conditions,
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the transgenic females suffered more readily from
hypoglycaemia, indicating an impaired ability of the
liver to initiate gluconeogenesis. The buffered fat
available to the heart may serve a crucial role in
protecting  this  essential  organ  from  gross
nutritional insufficiency under fasting conditions.
Notably, pericardial fat deposits have been shown
to be highly correlated with atherosclerotic plaque
in human studies, and in fact were found to be
more highly associated with early development of
coronary artery disease than simple anthropometric
measures of abdominal obesity [74]. 
MetS is a syndrome commonly defined as the
presence of at least three metabolic indicators
among a list of factors associated with increased
risk to cardiovascular disease. One of the main
objections to the use of the term is the lack of
a theory  that  adequately  explains  why  this
particular  set  of  metabolic  manifestations  –
dyslipidemia, high blood pressure, excess visceral
fat, and impaired glucose metabolism – should
coexist. In this paper, we have developed a novel
theory which can explain the mechanisms related
to MetS pathogenesis, based on the damaging
effects of a dietary excess of high-glycemic-index
carbohydrates, particularly fructose, in conjunction
with an avoidance of dietary cholesterol. We provide
support for the theory from several animal studies,
involving hamsters, baboons, and rodents, showing
a rapid and remarkable adverse effect of fructose
on liver function. A crucial piece of the puzzle is the
observation that glycated LDL is more susceptible
to oxidative damage, including oxidation of the
contained cholesteryl esters. 
Adipocyte  and  macrophage  dysfunction
contribute significantly to the disease process. 
Both in vitro and animal studies of cholesterol
metabolism by these cells reveal that they carry the
burden of extracting cholesterol from glycated LDL
and transporting it to HDL-A1 via a scavenger
mechanism.  In  the  process,  they  too  become
damaged, leading eventually to apoptosis and cell
death. AGE damage to apoE blocks the movement
of cholesterol from the ER to the PM, and excess
cholesterol accumulates in the ER. The adipocytes
become engorged with fatty deposits to buffer the
excess cholesterol, while simultaneously suffering
from depleted PM cholesterol. Subsequent defects
in the cholesterol supply chain, along with excessive
storage of 25-hydroxyvitamin D by the adipocytes,
leads to dysfunctional β cells in the pancreas along
with insulin resistance in the skeletal muscles and
other tissues. Distressed adipocytes secrete leptin,
angiotensin-II, and cytokines, which orchestrate
a major  restructuring  of  muscle  metabolism
towards favouring fats over glucose, and induce
macrophages to invade the adipose tissue to clean
up cell debris. 
The supply of triglycerides and glucose in the
bloodstream must be kept artificially high because
widespread insulin resistance interferes with the
utilizing of these nutrients for fuel. The depletion
of cholesterol in the adipocyte PM leads to sodium
leaks, and this will result in excess serum sodium
and in the activation of the renin-angiotensin
system leading to hypertension. Calcium hoarding
by adipocytes and insufficient cholesterol supply
likely contribute to impaired insulin synthesis and
secretion in pancreatic β cells. Finally, due to the
problem of ineffective supply from the bloodstream
lipid particles, private stashes of fat and cholesterol
accumulate ectopically. 
In  conclusion,  we  would  urge  medical  pra  -
ctitioners to encourage individuals exhibiting MetS
to strongly limit the consumption of dietary fructose
[75] and other high-glycemic-index carbohydrates,
and to stop discouraging them from consuming
foods rich in cholesterol [76]. 
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